RAPS Webcast: FDA Forecast: 2026

Virtual ProgramsVirtual Programs
Advanced therapies/cell and gene therapyAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIFoundationalGenericsHealth Authority meeting and communication strategyMedical DevicesNutritional/Natural HealthOTCOtherPharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)